The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2024

Filed:

Mar. 12, 2020
Applicant:

Charles River Laboratories, Inc., Wilmington, MA (US);

Inventor:

Qizhao Wang, Rockville, MD (US);

Assignee:

CHARLES RIVER LABORATORIES, INC., Wilmington, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/761 (2015.01); C07K 14/075 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 35/761 (2013.01); C07K 14/075 (2013.01); C12N 15/86 (2013.01); C12N 2710/10343 (2013.01); C12N 2750/14143 (2013.01);
Abstract

The present invention is directed to recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency, pharmaceutical compositions comprising such rAAV, and methods for their production and use. The present invention is particularly directed to recombinantly-modified adeno-associated virus (rAAV) that have been further modified to comprise Cis-Elements, including replication origins, promoters and enhancers, that are capable of regulating the replication of an rAAV genome and that improve rAAV replication. Preferably, such Cis-Elements are provided within domains of the rAAV that precede and/or follow the 5' and/or 3′ inverted terminal repeated sequences (ITR) of an rAAV. The invention particularly concerns the presence and the use of polynucleotide Cis-Elements that comprise actual or potential G-Quadruplex Sequences, polynucleotide Cis-Elements that comprise DNA sequences from wild-type AAV (wt AAV) and polynucleotide Cis-Elements that comprise DNA sequences from other viral genomes or from the human genome.


Find Patent Forward Citations

Loading…